aleozen (Recordati SpA)

Aleozen is a herbal dietary supplement developed and marketed in Tunisia, primarily by Opalia Pharma (a subsidiary of Recordati). It is formulated as a combination of plant extracts, typically including *Crataegus oxyacantha* (hawthorn), *Ballota nigra* (black horehound), and *Passiflora incarnata* (passionflower). These botanical ingredients are traditionally used for their sedative and anxiolytic properties to manage stress, minor anxiety, and sleep disturbances. The supplement is being investigated in clinical trials, such as the PHYTéS study led by Hôpital Universitaire Sahloul, for its potential efficacy in preventing and treating Post-Traumatic Stress Disorder (PTSD) in trauma-exposed patients.

Brand names

Aleozen